UK's Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024 | Goodwin
Earlier this year, the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), announced that a new International Recognition Procedure (IRP) will be...
United States United Kingdom Great Britain European Commission Decision Reliance Procedure European Union Committee For Medicinal Products Human
Source: jdsupra.com